JP2019528255A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528255A5
JP2019528255A5 JP2019503247A JP2019503247A JP2019528255A5 JP 2019528255 A5 JP2019528255 A5 JP 2019528255A5 JP 2019503247 A JP2019503247 A JP 2019503247A JP 2019503247 A JP2019503247 A JP 2019503247A JP 2019528255 A5 JP2019528255 A5 JP 2019528255A5
Authority
JP
Japan
Prior art keywords
protein
optionally
elution buffer
temperature
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528255A (ja
JP7092744B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/043384 external-priority patent/WO2018018011A2/en
Publication of JP2019528255A publication Critical patent/JP2019528255A/ja
Publication of JP2019528255A5 publication Critical patent/JP2019528255A5/ja
Priority to JP2022096278A priority Critical patent/JP7411020B2/ja
Application granted granted Critical
Publication of JP7092744B2 publication Critical patent/JP7092744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503247A 2016-07-22 2017-07-21 Fc含有タンパク質を精製する方法 Active JP7092744B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022096278A JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662365943P 2016-07-22 2016-07-22
US62/365,943 2016-07-22
PCT/US2017/043384 WO2018018011A2 (en) 2016-07-22 2017-07-21 Methods of purifying fc-containing proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022096278A Division JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Publications (3)

Publication Number Publication Date
JP2019528255A JP2019528255A (ja) 2019-10-10
JP2019528255A5 true JP2019528255A5 (https=) 2020-07-27
JP7092744B2 JP7092744B2 (ja) 2022-06-28

Family

ID=59656168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019503247A Active JP7092744B2 (ja) 2016-07-22 2017-07-21 Fc含有タンパク質を精製する方法
JP2022096278A Active JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022096278A Active JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Country Status (12)

Country Link
US (1) US11312745B2 (https=)
EP (1) EP3487867B1 (https=)
JP (2) JP7092744B2 (https=)
KR (2) KR102579850B1 (https=)
CN (2) CN109563125B (https=)
AU (2) AU2017298984B2 (https=)
CA (2) CA3218290A1 (https=)
IL (2) IL285146B (https=)
MA (1) MA45721A (https=)
MX (2) MX2019000903A (https=)
SG (1) SG11201900573UA (https=)
WO (1) WO2018018011A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112839959A (zh) * 2018-09-21 2021-05-25 特尼奥生物股份有限公司 用于纯化异源二聚多特异性抗体的方法
AU2019356564A1 (en) * 2018-10-11 2021-04-29 Amgen Inc. Downstream processing of bispecific antibody constructs
CA3123052A1 (en) * 2019-01-16 2020-07-23 Regeneron Pharmaceuticals, Inc. Method and system of identifying and quantifying antibody fragmentation
KR102286892B1 (ko) * 2019-07-08 2021-08-06 삼천당제약주식회사 안과용 단백질 제제의 정제방법
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法
CN112881675A (zh) * 2019-11-29 2021-06-01 广东菲鹏生物有限公司 IgM抗体检测稀释液
BR112022019841A2 (pt) 2020-04-09 2022-12-06 Cytomx Therapeutics Inc Composições contendo anticorpos ativáveis
EP4213958B1 (en) * 2020-09-16 2026-02-18 Waters Technologies Corporation Improved size exclusion chromatography utilizing low concentration amino acids in size exclusion chromatography mobile phase
CN118414350A (zh) * 2021-10-19 2024-07-30 阿特根公司 纯化具有igg fc结构域的融合蛋白的方法
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法
CN116165290B (zh) * 2021-12-17 2025-06-27 复旦大学 一种抗体药物研发流程中工程细胞株的筛选方法
CN116271982B (zh) * 2022-11-30 2024-01-09 杭州广科安德生物科技有限公司 一种血液高丰度蛋白免疫亲和柱的再生方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6713610B1 (en) 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
EP1690934A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP1500329B1 (en) 1996-12-03 2012-03-21 Amgen Fremont Inc. Human antibodies that specifically bind human TNF alpha
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
WO1999053059A1 (en) * 1998-04-16 1999-10-21 Genentech, Inc. Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
JP5553963B2 (ja) * 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド 組換え抗体をリフォールディングする方法
TWI372763B (en) * 2005-06-17 2012-09-21 Wyeth Llc Methods of purifying anti a beta antibodies
WO2007081906A2 (en) * 2006-01-06 2007-07-19 Amgen Inc. Purification by column-chromatography using eluants containing organic solvents
WO2007146968A2 (en) 2006-06-12 2007-12-21 Trubion Pharmaceuticals, Inc. Single-chain multivalent binding proteins with effector function
US10982250B2 (en) * 2006-09-18 2021-04-20 Genentech, Inc. Methods of protein production
US8198409B2 (en) * 2007-05-21 2012-06-12 Nomadic Bioscience Co., Ltd. Polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
ES2563027T3 (es) 2008-01-07 2016-03-10 Amgen Inc. Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática
EP2321338A1 (en) * 2008-08-14 2011-05-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
EA020621B1 (ru) * 2009-06-22 2014-12-30 Амген Инк. Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния
LT3660032T (lt) * 2009-06-25 2026-02-25 Amgen Inc. Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai
KR20120108967A (ko) 2009-09-16 2012-10-05 제넨테크, 인크. 코일드 코일 및/또는 테더 함유 단백질 복합체 및 그의 용도
CN102382190B (zh) * 2010-09-01 2014-04-09 山东新时代药业有限公司 分离和去除TNFR-Fc融合蛋白中寡聚体的方法
US20130317172A1 (en) 2010-12-24 2013-11-28 Nomadic Bioscience Co., Ltd. Method for immobilizing temperature responsive protein a
BR112014000352A2 (pt) * 2011-07-08 2017-02-14 Merck Sharp & Dohe Corp método de purificar uma proteína de fusão-fc, proteínas de fusão contendo fc purificada, tnfr:fc purificada, e tnfr:fc elevadamente purificada
US10189891B2 (en) * 2012-03-28 2019-01-29 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
EP2889617B1 (en) 2012-08-27 2017-10-11 Asahi Kasei Medical Co., Ltd. Antibody purification method by means of temperature-responsive chromatography
UY35148A (es) * 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US20140302037A1 (en) 2013-03-15 2014-10-09 Amgen Inc. BISPECIFIC-Fc MOLECULES
CN110627907B (zh) * 2013-11-04 2024-03-29 艾科诺斯科技股份有限公司 重靶向t细胞的异源二聚免疫球蛋白的产生

Similar Documents

Publication Publication Date Title
JP2019528255A5 (https=)
Cheung et al. Immobilized metal ion affinity chromatography: a review on its applications
CN103270044B (zh) 亲和色谱用载体和分离免疫球蛋白的方法
Valliere-Douglass et al. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions
WO2011162210A1 (ja) アミノ酸を利用したタンパク質の精製方法
JP5944101B2 (ja) 非グリコシル化タンパク質の精製
RU2019109975A (ru) Способы очистки антител
KR101908074B1 (ko) 개선된 FVIII:C/FVIII:Ag의 비를 갖는 인자 VIII의 제조방법
RU2012130151A (ru) Промывочный раствор и способ промывки для аффинной хроматографии
Walker et al. Techniques in Molecular Biology: Volume 2
JPWO2020209318A5 (https=)
JP6335785B2 (ja) ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子
Nascimento et al. Studies on the purification of antibody fragments
EP3054009A1 (en) PROTEIN COMPRISED BY LINKING BY LINKER MULTIPLE DOMAINS HAVING AFFINITY FOR PROTEINS HAVING Fc PART OF IMMUNOGLOBULIN G (IgG)
AU2020368409A1 (en) Methods for characterizing host-cell proteins
RU2011125656A (ru) Очистка полипептидов
CA2467048A1 (en) Method of protein purification
Westra et al. Immobilised metal-ion affinity chromatography purification of histidine-tagged recombinant proteins: a wash step with a low concentration of EDTA
Arakawa et al. Solvent modulation of column chromatography
CN103703015A (zh) 阳离子和阴离子交换层析法
JP5635682B2 (ja) 疎水性相互作用クロマトグラフィー法
JP6303379B2 (ja) 抗体の精製方法
EP4483188A1 (en) Size exclusion chromatography for characterizing host cell proteins
Arakawa et al. Mini review for niche downstream processes
JP2015003872A (ja) マウスIgGの精製方法